DNA Repair Pathways in Cancer Therapy and Resistance

Cited by (340)

Items 101–200 of 340

1. Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies
   Pietro Carotenuto, Sergio A. Gradilone, Brunella Franco · 2023 · Genes
2. Novel N-(4-thiocyanatophenyl)-1H-1,2,3-triazole-4-carboxamides exhibit selective cytotoxic activity at nanomolar doses towards human leukemic T-cells.
   N. Pokhodylo, N. Finiuk, O. Klyuchivska, M. Tupychak, V. Matiychuk, E. Goreshnik, R. Stoika · 2022 · European journal of medicinal chemistry
3. Histochemical and histomorphological evidence of the modulating role of 1-isothiocyanate-4-methyl sulfonyl butane on cisplatin-induced testicular-pituitary axis degeneration and cholesterol homeostasis in male Sprague-Dawley rats
   Sunday Aderemi Adelakun, Olalekan Wasiu Akintunde, Babatunde Ogunlade, Bisade Esther Adeyeluwa · 2022 · Morphologie
4. Extracellular vesicle-mediated chemoresistance in breast cancer: focus on miRNA cargo
   Maria Chiara Ciferri, Roberta Tasso · 2025 · Extracellular Vesicles and Circulating Nucleic Acids
5. Decrotonylation of cGAS K254 prompts homologous recombination repair by blocking its DNA binding and releasing PARP1
   Hejiang Guo, Yang Han, Shibo Yao, Bijia Chen, Hongling Zhao, Jia Jin, Shi Chen, Yuhao Liu, Shanshan Gao, Hua Guan et al. · 2024 · Journal of Biological Chemistry
6. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways
   Esraa Almalki, Abdullah Al-Amri, Reem Alrashed, Mohammed Mousa Al-Zharani, Abdelhabib Semlali · 2023 · International Journal of Molecular Sciences
7. Physapruin A Enhances DNA Damage and Inhibits DNA Repair to Suppress Oral Cancer Cell Proliferation
   Tzu-Jung Yu, C. Yen, Yuan-Bin Cheng, Chia-Hung Yen, J. Jeng, Jen-Yang Tang, Hsueh-Wei Chang · 2022 · International Journal of Molecular Sciences
8. Targeting DNA Damage Response and Immune Crosstalk in Cancer: Mechanistic Insights and Therapeutic Opportunities
   Lavinia Florica Mărcuț, Roxana Daniela Brata, Alina Cristina Barb, Alexia Manole, Dan Gabriel Stef, Cristina Ștefania Dumitru, Flavia Zara, Raul Pătrașcu · 2025 · International Journal of Molecular Sciences
9. Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome
   Elizabeth Vargas-Castellanos, Andrés Rincón-Riveros · 2025 · Cancer Medicine
10. SJB2-043, a USP1 Inhibitor, Suppresses A549 Cell Proliferation, Migration, and EMT via Modulation of PI3K/AKT/mTOR, MAPK, and Wnt Signaling Pathways
    Li-Peng Wu, Meng Yu, Huosheng Liang, Long Lin, Hua-Jian Li, Guangyang Chen, Halimulati Muhetaer, Jingjing Li, Bo Wu, Xuejing Jia et al. · 2025 · Current Issues in Molecular Biology
11. PARylation of GCN5 by PARP1 mediates its recruitment to DSBs and facilitates both HR and NHEJ Repair
    D. Sarkar, Amartya Chakraborty, Shaina Mandi, S. Dutt · 2024 · Cellular and Molecular Life Sciences
12. Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways
    Carolina Pires, I. Marques, A. Saramago, M. Moura, M. Pojo, Rafael Cabrera, Catarina Santos, Francisco Rosário, D. Lousa, João B. Vicente et al. · 2024 · International Journal of Cancer
13. Modular Hub Genes in DNA Microarray Suggest Potential Signaling Pathway Interconnectivity in Various Glioma Grades
    Marco A. Orda, Peter Matthew Paul Fowler, Lemmuel Lara Tayo · 2024 · Biology
14. Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines
    A. Baranoski, S. C. Semprebon, B. Biazi, Thalita Alves Zanetti, Amanda Cristina Corveloni, Lilian Areal Marques, S. Lepri, G. Coatti, M. Mantovani · 2024 · Journal of Toxicology and Environmental Health, Part A
15. Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
    Renzo Perales-Linares, N. Leli, Hesham Mohei, Silvia Beghi, Osvaldo D. Rivera, N. Kostopoulos, A. Giglio, Subin S. George, M. Uribe-Herranz, F. Costabile et al. · 2023 · Cancer Research
16. The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
    De-Qian Xie, Bo-Wen Jiang, Shi-Jin Wang, Qi-Fei Wang, Guang-Zhen Wu · 2023 · Frontiers in Cell and Developmental Biology
17. Whole grain metabolite 3,5-dihydroxybenzoic acid is a beneficial nutritional molecule with the feature of a double-edged sword in human health: a critical review and dietary considerations
    Waldemar Wagner, K. Sobierajska, Ł. Pułaski, A. Stasiak, W. Ciszewski · 2023 · Critical reviews in food science and nutrition
18. Global analysis of suppressor mutations that rescue human genetic defects
    Betül Ünlü, Carles Pons, Uyen Linh Ho, Amandine Batté, Patrick Aloy, Jolanda S. van Leeuwen · 2023 · Genome Medicine
19. Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway.
    Liu Dong, Hao-Qin Jiang, Zhi-Hua Kang, M. Guan · 2023 · Clinica chimica acta; international journal of clinical chemistry
20. Comparative analysis of chlorambucil-induced DNA lesion formation and repair in a spectrum of different human cell systems
    Sarah C Krassnig, Marina Mäser, N. A. Probst, Jens Werner, C. Schlett, Nina Schumann, G. von Scheven, A. Mangerich, A. Bürkle · 2023 · Toxicology Reports
21. Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine
    Trishna Saha Detroja, Rajesh Detroja, S. Mukherjee, A. Samson · 2022 · International Journal of Molecular Sciences
22. Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells
    Nikolaos Karantzelis, Michalis Petropoulos, V. de Marco, D. Egan, A. Fish, E. Christodoulou, D. Will, J. Lewis, A. Perrakis, Z. Lygerou et al. · 2022 · Frontiers in Pharmacology
23. Cleavage of Abasic Sites in DNA by an Aminoquinoxaline Compound: Augmented Cytotoxicity and DNA Damage in Combination with an Anticancer Drug Chlorambucil in Human Colorectal Carcinoma Cells
    Chandra Sova Mandi, T. Mahata, Dipendu Patra, Jeet Chakraborty, A. Bora, R. Pal, S. Dutta · 2022 · ACS Omega
24. Gossypin induces apoptosis and autophagy via the MAPK/JNK pathway in HT-29 human colorectal cancer cells
    Jun-Mo Moon, Sang-Woo Lee, Yun-Seo Jang, Su-A Lee, Soo-Hyun Jung, Sang-Ki Kim, B. Park, Young-Seok Park, byeong-Soo Kim, Myeon-Sik Yang et al. · 2025 · International Journal of Molecular Medicine
25. DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance
    Ludovica Gaiaschi, Claudio Casali, Andrea Stabile, Sharon D'Amico, Mauro Ravera, Elisabetta Gabano, Andrea Galluzzo, Cristina Favaron, Federica Gola, Fabrizio De Luca et al. · 2025 · Cell Proliferation
26. Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy
    Anna Piscone, Francesca Gorini, Susanna Ambrosio, Anna Noviello, Giovanni Scala, Barbara Majello, Stefano Amente · 2025 · Cells
27. Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer
    Zong-Lin Li, X. Shu, Xin Liu, Qiu Li, Yi-Fu Hu, Bing Jia, Min Song · 2024 · International Journal of General Medicine
28. A physicochemical model of X-ray induced photodynamic therapy (X-PDT) with an emphasis on tissue oxygen concentration and oxygenation
    F. Hosseini, N. Naghavi, A. Sazgarnia · 2023 · Scientific Reports
29. Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy
    Massimiliano Cazzaniga, Giordano Bruno Zonzini, Francesco Di Pierro, Chiara Maria Palazzi, Marco Cardinali, Alexander Bertuccioli · 2023 · Pathology & Oncology Research
30. Sanitation Enzymes: Exquisite Surveillance of the Noncanonical Nucleotide Pool to Safeguard the Genetic Blueprint.
    Kirsten Broderick, M. Moutaoufik, Khaled A. Aly, M. Babu · 2023 · Seminars in Cancer Biology
31. Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer
    Lia Tesfay, Bibbin T. Paul, Poornima Hegde, MOLLY A. BREWER, Samrin F. Habbani, Evan R. Jellison, Timothy M. Moore, Hao Wu, Suzy V. Torti, Frank M. Torti · 2022 · Scientific Reports
32. Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas
    Lia Pinto, Hanane Baidarjad, Natacha Entz‐Werlé, Eric Van Dyck · 2021 · Cancers
33. Deciphering molecular pathways in urological cancers: A gateway to precision therapeutics
    Kiavash Hushmandi, Najma Farahani, Behzad Einollahi, Shokooh Salimimoghadam, Mina Alimohammadi, Liping Liang, Le Liu, Gautam Sethi · 2025 · Journal of Advanced Research
34. Machine Learning–Enhanced Quantitative Structure-Activity Relationship Modeling for DNA Polymerase Inhibitor Discovery: Algorithm Development and Validation
    Samuel Kakraba, S. Ayyadevara, Aayire Yadem Clement, K. E. Abraham, C. Compadre, R. Shmookler Reis · 2025 · JMIR AI
35. AZD1390, an Ataxia telangiectasia mutated inhibitor, enhances cisplatin mediated apoptosis in breast cancer cells
    Deniz ÖZDEMİR, Can Ali Ağca · 2024 · Experimental Cell Research
36. DNA break induces rapid transcription repression mediated by proteasome-dependent RNAPII removal
    Shuaixin He, Zhiyuan Huang, Yang Liu, Taekjip Ha, Bin Wu · 2024 · Cell Reports
37. Solasodine targets NF-κB signaling to overcome P-glycoprotein mediated multidrug resistance in cancer.
    Pradhapsingh Bharathiraja, Karankumar Balamurugan, Chandramohan Govindasamy, N. Prasad, P. Pore · 2024 · Experimental Cell Research
38. Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis
    Dipankor Chatterjee, S. Mou, Tamanna Sultana, Md. Ismail Hosen, Md Omar Faruk · 2024 · Scientific Reports
39. AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells
    B. Lapa, M. I. Costa, Diana Figueiredo, J. Jorge, R. Alves, A. Monteiro, B. Serambeque, M. Laranjo, M. Botelho, I. Carreira et al. · 2023 · International Journal of Molecular Sciences
40. The anticancer/cytotoxic effect of a novel gallic acid derivative in non‐small cell lung carcinoma A549 cells and peripheral blood mononuclear cells from healthy individuals and lung cancer patients
    Shohreh Jafarinejad, William H. C. Martin, Bayan Abu Ras, M. Isreb, Badie K. Jacob, Abid Aziz, Z. Adoul, Ruby Lagnado, R. Bowen, M. Najafzadeh · 2023 · Biofactors
41. Caffeine enhances chemosensitivity to irinotecan in the treatment of colorectal cancer
    Seobin Yoon, Bum‐Kyu Lee, Keun Pil Kim · 2023 · Phytomedicine
42. Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents
    B. Rushing · 2023 · International Journal of Molecular Sciences
43. OGG1 competitive inhibitors show important off-target effects by directly inhibiting efflux pumps and disturbing mitotic progression
    Xhaferr Tanushi, G. Pinna, Marie Vandamme, C. Siberchicot, Ostiane D'Augustin, A. Di Guilmi, J. Radicella, B. Castaing, Rebecca Smith, S. Huet et al. · 2023 · Frontiers in Cell and Developmental Biology
44. Natural killer cell-mimicking nanomaterial for overcoming the multidrug resistance of tumor via cascade catalysis
    Min-Jie Li, Fan Gao, Qian‐Xiao Huang, Jun Feng, Chuan‐Jun Liu, S. Gong, Xian-Zheng Zhang · 2022 · Science China Materials
45. N4-acetylcytidine and other RNA modifications in epitranscriptome: insight into DNA repair and cancer development
    Eva Bártová, Lenka Stixová, Alena Svobodová Kovaříková · 2025 · Epigenomics
46. Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review
    Bin Liu, Zi-Yu Wang, Meng Gu, Jinghui Wang, Jinjing Tan · 2024 · Translational Lung Cancer Research
47. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer
    Connor J. Hughes, Christopher Alderman, Arthur Wolin, Kaiah M. Fields, Rui Zhao, H. Ford · 2024 · Biochimica et biophysica acta. Reviews on cancer
48. Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells
    Nazita Tavazohi, M. Mirian, J. Varshosaz, Shiva Shirani-Bidabadi, Hamid Mir Mohammad Sadeghi, H. Khanahmad · 2023 · Journal of Drug Delivery Science and Technology
49. Protective Effects of Piceatannol on DNA Damage in Benzo[a]pyrene-Induced Human Colon Epithelial Cells.
    Chun-Han Chang, You-Tsz Lien, Wei-Sheng Lin, K. Nagabhushanam, Chi-Tang Ho, Min-Hsiung Pan · 2023 · Journal of Agricultural and Food Chemistry
50. In situ supramolecular self-assembly for alleviating multidrug resistance in cancer
    Jie Zhao, Xiao-Bo Wu, Jia-Li Chen, Chengling Wu, Rui-Jia Zhang, Qingxin Yao, Jian-Jun Xie, Yuan Gao · 2023 · Supramolecular Materials
51. Computational Methods Summarizing Mutational Patterns in Cancer: Promise and Limitations for Clinical Applications
    Andrew Patterson, Abdurrahman Elbasir, Bin Tian, Noam Auslander · 2023 · Cancers
52. Antitumoral effect of novel synthetic 8-hydroxy-2-((4-nitrophenyl)thio)naphthalene-1,4-dione (CNN16) via ROS-mediated DNA damage, apoptosis and anti-migratory effect in colon cancer cell line.
    E. D. da Silva, F. P. Mesquita, Ingryd Nayara de Farias Ramos, Carinne Borges de Souza Moraes Rego Gomes, Caroline dos Santos Moreira, V. Ferreira, D. D. da Rocha, Marcelo de Oliveira Bahia, C. A. Moreira-Nunes, Carolina Rosal Teixeira de Souza et al. · 2022 · Toxicology and Applied Pharmacology
53. RAS-mediated tumor stress adaptation and the targeting opportunities it presents
    Alexandra Redding, Andrew E. Aplin, Elda Grabocka · 2022 · Disease Models & Mechanisms
54. Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based Studies
    R. Manguinhas, P. A. Serra, Nuno Gil, R. Rosell, Nuno G. Oliveira, R. C. Guedes · 2024 · Cancers
55. Sitagliptin synergizes 5‐fluorouracil efficacy in colon cancer cells through MDR1‐mediated flux impairment and down regulation of NFκB2 and p‐AKT survival proteins
    Asmaa Eisa, S. Hanafy, H. Khalil, M. Elshal · 2024 · Journal of biochemical and molecular toxicology
56. The heterogeneity of breast cancer metastasis: a bioinformatics analysis utilizing single-cell RNA sequencing data
    Ardo Sanjaya, Hana Ratnawati, O. A. Adhika, Faiz Rizqy Rahmatilah · 2024 · Breast Cancer Research and Treatment
57. Molecular dynamics of DNA repair and carcinogen interaction: Implications for cancer initiation, progression, and therapeutic strategies
    Eman Alyafeai, Eskandar Qaed, Haitham Saad Al-mashriqi, Ahmed Al‐Maamari, Anisa H Almansory, Fatima Al Futini, Marwa Sultan, Zeyao Tang · 2024 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
58. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment
    J. Raguz, Catarina Pinto, T. Pölzlbauer, M. Habbeddine, Sandra Rosskopf, Judith Strauss, Valentin Just, S. Schmidt, Katell Bidet Huang, Felix Stemeseder et al. · 2024 · Journal for ImmunoTherapy of Cancer
59. Enzymatic Processing of DNA–Protein Crosslinks
    Maram M. Essawy, Colin Campbell · 2024 · Genes
60. Feasibility of Inferring Spatial Transcriptomics from Single-Cell Histological Patterns for Studying Colon Cancer Tumor Heterogeneity
    Michael Y. Fatemi, Yunrui Lu, Cyril Sharma, Eric Feng, Z. Azher, Alos B. Diallo, G. Srinivasan, Grace M. Rosner, K. Pointer, B. Christensen et al. · 2023 · medRxiv
61. Reactive oxygen species-responsive polyprodrug micelles deliver cell cycle regulators for chemosensitization.
    Ying Sun, Qimeng Wu, Quanyou Fu, Hai-Lin Cong, You-Qing Shen, Bing Yu, Haoran Hu · 2023 · Talanta: The International Journal of Pure and Applied Analytical Chemistry
62. Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor
    Justin W. Magrath, D. Flinchum, Alifiani B. Hartono, Ilon N Goldberg, Madelyn Espinosa-Cotton, K. Moroz, N. Cheung, Sean B. Lee · 2023 · Sarcoma
63. Identification and evaluation of a novel PARP1 inhibitor for the treatment of triple-negative breast cancer
    Rong Gong, Zhong-Ye Ma, LinHao He, Shilong Jiang, Dongsheng Cao, Yan Cheng · 2023 · Chemico-Biological Interactions
64. MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients
    Josef Horak, Alexandra Dolníková, Özge Cumaoğulları, Andrea Čumová, Nazila Navvabi, Ľudmila Vodičková, Miroslav Levý, Michaela Schneiderová, Václav Liška, Ladislav Anděra et al. · 2022 · Frontiers in Oncology
65. Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state
    Caterina Carraro, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Arik Horne, Marie Oestreich, Stefanie Warnat‐Herresthal, Tim Helbing, Michele De Franco, Kristian Händler, Sach Mukherjee et al. · 2022 · eLife
66. Terpenoids: Emerging Natural Modulators for Reversing ABC Transporter-Mediated Multidrug Resistance in Cancer Chemotherapy
    Lanfei Ma, Dina Mahemuti, Y. Lan, Jianxiong Xu, Wen-Fang Li, Zhengding Su, Jin-Yao Li, Aytursun Abuduwaili, Ayitila Maimaitijiang · 2026 · Pharmaceuticals
67. Tumor-associated macrophages contribute to cisplatin resistance via regulating Pol η-mediated translesion DNA synthesis in ovarian cancer
    Bilash Chatterjee, Mrinmoy Sarkar, Debanjana Ghosh, Sangita Mishra, Subhankar Bose, Md Maqsood Ahamad Khan, Senthil Kumar Ganesan, Nabanita Chatterjee, Amit Kumar Srivastava · 2025 · Cellular and Molecular Life Sciences
68. Advances and future directions in radiopharmaceutical delivery for cancer treatment
    Sikander Ailawadhi, Deanna Pafundi, Jennifer Peterson · 2025 · Expert Review of Anticancer Therapy
69. Long non-coding RNA LIP interacts with PARP-1 influencing the efficiency of base excision repair
    You Zuo, Jiaqian He, Zheng-Gui Zhou, Jingjing Sun, Can Ouyang, Hui Huang, Ya-Juan Wang, Hai-Rong Liu, Simon H. Reed · 2024 · Non-coding RNA Research
70. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance
    Zhujun Xu · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
71. Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells
    Huan He, Shao-Zheng Wang, Wen Zhang, Shan-Shan Gao, Hua Guan, Ping-Kun Zhou · 2023 · BMC Cancer
72. A Comprehensive Primer on Radiation Oncology for Non-Radiation Oncologists
    A. Beddok, Ruth Lim, J. Thariat, H. Shih, G. El Fakhri · 2023 · Cancers
73. A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres
    Venturina Stagni, Archontia Kaminari, Claudia Contadini, Daniela Barilà, Rosario Luigi Sessa, Zili Sideratou, Spiros Vlahopoulos, Dimitris Tsiourvas · 2023 · Cancers
74. 2,4-Dinitrophenol as an Uncoupler Augments the Anthracyclines Toxicity against Prostate Cancer Cells
    G. Adamczuk, E. Humeniuk, Kamila Adamczuk, A. Grabarska, J. Dudka · 2022 · Molecules
75. Dynamic Modelling of DNA Repair Pathway at the Molecular Level: A New Perspective
    Paola Lecca, Adaoha Ihekwaba · 2022 · Frontiers in Molecular Biosciences
76. Enhanced ETS1 stability by DNAPKcs orchestrates transcriptional changes during chemoresistance in triple negative breast cancer
    Aiindrila Dhara, Imlimaong Aier, Souhadri Das, Manash Sarkar, Ramandeep Kaur, Pritish Kumar Varadwaj, Samrat Daripa, Sumit Kumar Hira, Anindya Halder, Nirmalya Sen · 2025 · npj Breast Cancer
77. Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy.
    A. Kadry, Mai Adel, S. Abubshait, Galal Yahya, Marwa Sharaky, Rabah A. T. Serya, K. Abouzid · 2025 · Bioorganic & Medicinal Chemistry
78. Efficacy and Safety of PARP Inhibitors in Prostate Cancer: An Umbrella Review of Systematic Reviews and Meta-analyses.
    Chih-Chen Tzang, Hui-Wen Wu, Chiao-An Lou, Yong-Tang Li, Yuan-Fu Kang, C. Hsieh, Chen-Yu Lee, Tsai-Ching Hsu, B. Tzang · 2025 · Critical reviews in oncology/hematology
79. Role of BRCA1 in glioblastoma etiology
    Emirhan Harbi, Michael Aschner · 2024 · Cellular Oncology
80. Network‐based identification of key proteins and repositioning of drugs for non‐small cell lung cancer
    O. Adeyemo, Zainab Ashimiyu-Abdusalam, Mary Adewunmi, T. Ayano, Muhammad Sohaib, Reem Abdel-Salam · 2024 · Cancer Reports
81. Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
    Jianping Guo, Zhizhong Xiong, Shi Yin, Yue-e Wen, Longyang Jin, Caiqin Wang, Huaxian Chen, Dandong Luo, Zijian Deng, Dayin Huang et al. · 2023 · World Journal of Surgical Oncology
82. Creatine kinase brain-type regulates BCAR1 phosphorylation to facilitate DNA damage repair
    Bo Hee Yang, Wentao Zhang, Le Sun, Bin Lu, Changsong Yin, Yaoyang Zhang, Hong Jiang · 2023 · iScience
83. Integrated single-cell and bulk RNA sequencing reveals prognostic and immunotherapy-associated myofibroblastic cancer-associated fibroblast subtypes in head and neck squamous cell carcinoma
    X. Qiu, Yuhao Lin, Qian Li, A. Asarkar, Zhi-Heng Ke, Yi-Ying Xu, Li-Sha Chen · 2023 · Translational Cancer Research
84. DNA Damage Repair Proteins, HSP27, and Phosphorylated-HSP90α as Predictive/Prognostic Biomarkers of Platinum-based Cancer Chemotherapy: An Exploratory Study
    M. Sottile, F. D. Cuello-Carrión, L. Gómez, S. Semino, J. Ibarra, María B. García, L. Gonzalez, L. Vargas-Roig, S. Nadin · 2022 · Applied immunohistochemistry & molecular morphology (Print)
85. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma
    Liesbeth Everix, Shankari Nair, Cathryn H. S. Driver, Ingeborg Goethals, Mike Machaba Sathekge, Thomas Ebenhan, Charlot Vandevoorde, Julie Bolcaen · 2022 · Cancers
86. Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives
    Ya-Jing Liu, Yu-Wei Liu, Ting-Ting Wu, XiaoMing Bai, Shu-Man Wang, Luyun Zhang, Zhi-Wen Fu, Chen Shi · 2026 · Cancer Biology and Medicine
87. Cancer-associated fibroblast-derived GAS6 increases resistance to chemotherapy through AXL/STAT3/ABCG1 in gastric cancer
    Tae Hoon Kim, Dagyeong Lee, Hye Jeong Oh, In-Hye Ham, Tuyen Thanh Tran, Yulim Lee, Tae-Min Kim, Rolf A. Brekken, Zhang Zhang, Ding Ke et al. · 2025 · British Journal of Cancer
88. CRISPR/Cas as a tool to overcome drug resistance in cancer: From challenge to opportunity
    Bashdar Mahmud Hussen, Snur Rasool Abdullah, Hazha Jamal Hidayat, Mark Charles Glassy, Arash Safarzadeh, Alireza Komaki‬, Majid Samsami, Mohammad Naser Taheri · 2025 · Molecular and Cellular Probes
89. The Essence of Nature Can be the Simplest (4)–Adenine: Powerful Reserve for Extracellular Fenton Chemistry
    Qunfu Wu, Jiao Zhou, Dong-Lou Wang, Xue-Mei Niu · 2025 · Chemistry and Biodiversity
90. LA-ICP-TOFMS Imaging Reveals Significant Influence of Cancer Cell Resistance on Oxaliplatin Compartmentalization in the Tumor Microenvironment
    M. Schaier, Dina Baier, S. Theiner, Walter Berger, G. Koellensperger · 2025 · JACS Au
91. Phase separation in DNA repair: orchestrating the cellular response to genomic stability
    Ju-Xin Deng, Zhao-Yang Du, Lei Li, Min Zhu, Hong-Chang Zhao · 2025 · PeerJ
92. Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research
    Nauf Bou Antoun, Hiba-Tun-Noor Afshan Mahmood, Anthony J. Walker, H. Modjtahedi, R. Grose, A. Chioni · 2025 · International Journal of Molecular Sciences
93. Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
    Barbara Mora-Lagos, M. E. Reyes, L. Lobos-González, M. del Campo, K. Buchegger, Louise Zanella, I. Riquelme, C. Ili, P. Brebi · 2025 · Biological Research
94. CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models
    Rita Sala, Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, L. Pike, Qiong Zhou, W. Messersmith, Daniel V. LaBarbera · 2024 · International Journal of Molecular Sciences
95. The Emerging Role of Long Noncoding RNAs in Sorafenib Resistance Within Hepatocellular Carcinoma
    Puneet Vij, M. Hussain, Sanjaya K. Satapathy, Everardo Cobos, Manish K. Tripathi · 2024 · Cancers
96. Artemis and its role in cancer
    A. Parsyan, Vasudeva Bhat, Harjot K. Athwal, Emily A. Goebel, Alison L. Allan · 2024 · Translational Oncology
97. Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors
    Arba Karcini, Nicole R. Mercier, Iulia M. Lazar · 2024 · Frontiers in Pharmacology
98. Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus
    A. Youssef, A. N. Zekri, M. Mohanad, S. Loutfy, N. A. Abdel Fattah, M. Elberry, Asmaa Elleithy, Ahmed S. EL-Touny, A. Rabie, M. Shalaby et al. · 2023 · Clinical and Experimental Medicine (Testo stampato)
99. Looking at Biomolecular Interactions through the Lens of Correlated Fluorescence Microscopy and Optical Tweezers
    Anahita Haghizadeh, M. Iftikhar, Shiba S. Dandpat, Trey Simpson · 2023 · International Journal of Molecular Sciences
100. Suitability of salivary leucocytes to assess DNA repair ability in human biomonitoring studies by the challenge-comet assay.
     N. Fernández-Bertólez, Carlota Lema-Arranz, S. Fraga, J. Teixeira, E. Pásaro, L. Lorenzo-López, V. Valdiglesias, B. Laffon · 2022 · Chemosphere